VFVictoria Fleming

Victoria Fleming

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Victoria Fleming has a total of 98 co-authors. Here are the top co-authors by number of shared publications:

  • Beau M. Ances

    Department of Neurology Washington University School of Medicine St. Louis Missouri USA

    6 shared publications
  • Annie Cohen

    Behavioral Health Service Line, VA Pittsburgh Healthcare System Pittsburgh Pennsylvania USA

    5 shared publications
  • Bradley T. Christian

    Waisman Center University of Wisconsin–Madison Madison Wisconsin USA

    5 shared publications
  • Mark Mapstone

    Department of Neurology University of California Irvine School of Medicine Irvine California USA

    5 shared publications
  • Ozioma Okonkwo

    Department of Geriatrics and Gerontology School of Medicine and Public Health, University of Wisconsin‐Madison Madison Wisconsin USA

    5 shared publications
  • Benjamin Handen

    Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA

    4 shared publications

Latest Publications

  • Open Access

    Timing and risk of age-related conditions in individuals with Down syndrome

    by Hannah F. Tavalire, Akaninyene Noah, Veronica Fitzpatrick, Hannah Graham, Shelly Verma, Laura Krohn, Victoria L. Fleming-Batayneh, Katie Frank, Daniel Vockeroth, Brian Chicoine

    Individuals with Down syndrome (DS) exhibit accelerated biological aging and unique patterns in disease prevalence. However, empirical characterizations of relative risk and age at onset of disease in this population are not common. Here we aimed to quantify the difference in risk and timing of age-related conditions between individuals with DS when compared to typically developing (TD) matched controls. We used semiparametric Cox proportional hazards models and Restricted Mean Event-Free Age (RMEA) to estimate differences in risk and approximate average age at onset of cataracts, cognitive decline, death, menopause, and osteoporosis. Individuals with DS were at higher risk of all age-related conditions or events and experienced these events at younger ages, excluding menopause. We observed a 24.5-fold higher risk of cognitive decline in individuals with DS (p<0.001), and between a 2- and 4-fold higher risk of the other age-related events or conditions (p<0.01). Cognitive decline and death occurred more than 14 years earlier in individuals with DS and were more likely to co-occur (p<0.001) compared to in TD individuals. These findings have important implications for tailored screening and prevention efforts in aging individuals with DS, as this population experiences a distinct cadence of age-related events. Author Summary: Here we characterize differences in when individuals with Down syndrome (DS) experience age-related conditions and events relative to typically developing (TD) individuals. Individuals with DS experienced cataracts, cognitive decline, death, and osteoporosis at a younger age and were at higher risk for these conditions than typically developing individuals. Most notably, we found that individuals with DS are at a 24.5-fold greater risk of cognitive decline and experience cognitive decline 14.7 years before TD individuals. We observed a similar age disparity in time of death (14.2-year difference), with median age at time of death estimating an even more substantial gap of 23.4 years between cohorts. We detected no difference in the timing or risk of menopause between groups. We also observed that the rate at which individuals with DS experience more than one of these age-related conditions differed significantly from TD controls, with death and cognitive decline co-occurring most often. These findings exemplify the need for tailored screening and prevention efforts in individuals with DS, moving away from general guidelines developed in TD populations.

  • Open Access

    Inflammation Associated With Obesity, Aging, and Amyloid Burden in Adults With Down Syndrome

    by Victoria L. Fleming‐Batayneh, Brian C. Helsel, Lauren T. Ptomey, Benjamin L. Handen, Mark Mapstone, Melissa Petersen, Sharon J. Krinsky‐McHale, Christy L. Hom, Davneet Minhas, Weiquan Luo, et al.

    Objective: Adults with Down syndrome (DS) often show elevated systemic inflammation, but the association with obesity, aging, and Alzheimer's disease (AD) pathology is not well understood. Methods: Data were drawn from 188 nondemented adults with DS participating in the Alzheimer Biomarkers Consortium‐DS (ABC‐DS). Participants completed clinical assessments, blood draws, and neuroimaging. Plasma biomarkers included indicators of general, pro‐, and anti‐inflammation. Mixed linear models tested associations between BMI, age, PET‐measured amyloid burden, and inflammatory biomarkers, adjusting for sex, trisomy type, and collection site. False discovery rate correction was applied. Results: The majority of the participants met criteria for obesity. Higher BMI was significantly associated with elevated levels of CRP, IL‐6, TNF‐α, B2M, IL‐18, and slCAM‐1 ( p < 0.05). Older age was significantly associated with higher B2M ( β = 1.22e + 05, p < 0.001). Amyloid burden was positively associated with IL‐6 ( β = 0.005, p = 0.037). Conclusions: Obesity, aging, and amyloid burden relate to systemic inflammation in adults with DS. Obesity showed the strongest and most consistent associations, emphasizing the value of regular monitoring and weight management strategies to help reduce inflammation. Aging and early amyloid accumulation showed more limited links with systemic inflammation; future work should examine whether these processes are more closely related to biomarkers of neuroinflammation as AD progresses.

  • The joint association of obesity and physical activity on cognitive function in Down syndrome

    by Julianne G Clina, Brian C Helsel, Sigan L Hartley, Victoria L Fleming-Batayneh, Benjamin Handen, Bradley Christian, Elizabeth Head, Mark Mapstone, Christy L Hom, Jeffrey Burns, et al.

    Background: Lifetime incidence of Alzheimer's disease (AD) in Down syndrome (DS) exceeds 90%. In adults with and without DS, low moderate-to-vigorous physical activity (MVPA) and obesity have independently been associated with AD. Research across other disease conditions indicates MVPA may attenuate some negative consequences of obesity. Objective: To evaluate the potential joint association of obesity and MVPA on cognitive function in adults with DS. Methods: Seventy-five adults with DS (age 39.1 years, 46.7% female) enrolled in the Alzheimer Biomarker Consortium-Down Syndrome (ABC-DS) study and completed a 7-day accelerometer protocol. Cognitive function was assessed using the ABC-DS cognitive battery. Participants were categorized with Obesity (body mass index (BMI) ≥ 30 kg/m 2 ) or No Obesity (BMI < 30 kg/m 2 ). A median split of MVPA was then used to create four groups: No Obesity/High PA (n = 18), No Obesity/Low PA (n = 16), Obesity/High PA (n = 20), and Obesity/Low PA (n = 21). Linear models were used to compare cognitive function across groups. Results: The Obesity/High PA group performed better than the No Obesity/Low PA group for episodic memory (β = 4.86, p = 0.009), executive functioning (β = 3.07, p = 0.013), and dementia symptoms (β = −6.57, p = 0.022). The Obesity/High PA group also performed better than the Obesity/Low PA group for memory and orientation (β = 4.43, p = 0.012), social functioning (β = 4.52, p = 0.006), visuo-spatial processing (β = −2.39, p = 0.038), and overall dementia symptoms (β = −7.21, p = 0.016). There were no assessments for which either high PA group performed worse than either Low PA group. Conclusions: Physical activity may benefit AD-related cognitive function in persons with DS, regardless of obesity status.


  • Open Access

    Physical activity as a resistance or resilience mechanism in Down syndrome Alzheimer's disease

    by Victoria L. Fleming, Jamie Peven, Brian C. Helsel, Lauren T. Ptomey, Julianne Clina, Ashlyn Barry, Beau M. Ances, Benjamin L. Handen, Bradley T. Christian, Charles Laymon, et al.

    INTRODUCTION: Adults with Down syndrome (DS) are at risk for Alzheimer's disease (AD). Lifestyle factors such as engagement in moderate‐to‐vigorous physical activity (MVPA) reduce risk or delay the onset of AD. This study aimed to determine whether MVPA confers a resistance (AD pathology) or resilience (cognitive decline) effect on the relationship between AD pathology and cognitive decline in DS. METHODS: Analyses included 69 adults with DS (aged 26–58) who participated in a longitudinal study across 3.29 years. An actigraphy accelerometer assessed MVPA across 7 days. Directly administered and informant‐reported measures assessed cognitive functioning, specifically memory and dementia symptoms. Neuroimaging biomarkers quantified amyloid beta (Aβ) burden, as assessed via positron emission tomography imaging. RESULTS: In regression models, baseline MVPA was not associated with baseline level or change in global Aβ burden across 32 months. However, baseline MVPA ( β = −0.005 to −0.004, p < 0.05) significantly moderated the association between increases in Aβ burden and declines in cognitive functioning. Adults with DS who engaged in greater MVPA experienced less cognitive decline compared to adults with DS who engaged in less MVPA, who had similar Aβ load. DISCUSSION: MVPA may help maintain cognitive functioning early in the progression of AD pathology in adults with DS. Highlights: Adults with Down syndrome are genetically at risk for Alzheimer's disease (AD). Timing of AD clinical onset spans 30+ years. Physical activity has been linked to less cognitive decline and dementia symptoms. Physical activity may protect against dementia through resilience mechanisms. Physical activity could be a low‐cost intervention to help prevent cognitive decline.


  • Open Access

    Longitudinal study of body mass index in relation to Alzheimer's disease pathology and symptomatology in Down syndrome

    by Victoria L. Fleming, Brian C. Helsel, Lauren T. Ptomey, Benjamin L. Handen, Sharon J. Krinsky‐McHale, Christy L. Hom, Matthew Zammit, Davneet Minhas, Weiquan Luo, Charles Laymon, et al.

    INTRODUCTION: Weight loss has been linked to early Alzheimer's disease (AD) pathology, possibly through metabolic dysregulation. We examined changes in body mass index (BMI) in relation to AD biomarkers (amyloid beta [Aβ] and tau) and cognitive decline in adults with Down syndrome (DS). We hypothesized that BMI decline would track with early AD pathology and cognitive decline.METHODS: Adults with DS (N = 467; Mage = 43.67 ± 10.06) completed one to four data cycles (≈16 months apart). Linear mixed models examined BMI change over time by age, positron emission tomography (PET) Aβ and tau, and changes in memory and dementia symptoms.RESULTS: BMI declined with age‐by‐time (β = −0.014, p = 0.002) and baseline PET Aβ‐by‐time (β = −0.005, p = 0.002). On average, BMI decline began in the early 40s and was related to decline in memory and overall cognitive functioning.DISCUSSION: Weight loss is associated with the presence of Aβ and cognitive decline in adults with DS. Longitudinal studies need to clarify directionality and biological mechanisms.Highlights: Adults with Down syndrome (DS) are at an elevated risk for Down Syndrome assocaited Alzheimer's disease (DSAD). On average, adults with DS experience body mass index (BMI) decline beginning in their early 40s. Positron emission tomography amyloid beta deposition is associated with greater decline in BMI in adults with DS. Across time, AD‐related memory declines are associated with BMI decline. BMI decline should be part of DSAD screening tools, as it is an important part of DSAD clinical disease expression.


  • Open Access

    Eye Tracking as a Tool for Detecting Alzheimer's Disease in People With Down Syndrome

    by Brianna Piro‐Gambetti, Sharon Krinsky‐McHale, Cynthia Kovacs, Benjamin Handen, Bradley Christian, Charles M. Laymon, Davneet Minhas, Weiquan Luo, Dasoo Milton Yoon, Victoria L. Fleming, et al.

    Background: Adults with Down syndrome (DS) experience an increased risk of Alzheimer's disease (AD). Valid cognitive assessments for adults with DS with severe/profound intellectual disability (ID) are needed. It is unclear whether eye tracking is feasible for detecting AD in DS.Method: Fifty‐three adults with DS completed a visual paired comparison (VPC) task, a battery of cognitive measures, and underwent PET scanning. Study partners reported on the participant's dementia symptoms. Bivariate correlations assessed associations between eye‐tracking metrics and AD‐related pathology and symptomatology. Analyses included the full sample (n = 53) and a subgroup with an IQ ≤ 45 (n = 33).Results: Greater fixation duration during the habituation phase was associated with better cognitive performance on the Modified Cued Recall Test (mCRT) (intrusions: r = −0.39, p = 0.011) and less PET tau (r = −0.47, p = 0.014). Larger saccadic amplitudes during the test phase were associated with younger age (r = −0.45, p < 0.001), better cognitive performance on the mCRT (total: r = 0.31, p = 0.041; intrusions: r = −0.33, p = 0.032) and less PET Aβ (r = −0.40, p = 0.025). Greater preference to fixate on the novel image was associated with fewer dementia symptoms (count: r = −0.44, p = 0.002; duration: r = −0.38, p = 0.009). This pattern of significance remained for the subgroup with lower IQ scores.Conclusion: The VPC task is a potentially useful method for assessing AD‐related cognitive impairments in adults with DS across varying ID levels.


  • Open Access

    Physical activity and physical and mental health in middle‐aged adults with Down syndrome

    by Victoria Fleming, Brianna Piro‐Gambetti, Benjamin Handen, Bradley T. Christian, Annie Cohen, Dana Tudorascu, David T. Plante, Ozioma Okonkwo, Sigan L. Hartley

    Adults with Down syndrome have an increased risk of aging‐related physical and mental health conditions and experience them at an earlier age than the general population. There is a need to investigate modifiable lifestyle factors that may reduce risk for these conditions. The present study investigated the associations between physical activity (i.e., sedentary behavior and moderate‐to‐vigorous activity) assessed via accelerometer across 7 days and caregiver‐reported physical and mental health of 66 nondemented middle‐aged adults with Down syndrome aged 25–55 years (52% female). Regression analyses indicated that more time spent in moderate intensity physical activity was associated with less risk of sleep apnea (β = −0.031, p = 0.004) and endocrine/metabolic conditions (β = −0.046, p = 0.009), and lower total number of physical health conditions (β = −0.110, p = 0.016) and anxiety disorders (β = −0.021, p = 0.049) after controlling for relevant sociodemographics. After also adjusting for body‐mass‐index (BMI), the association between time spent in moderate intensity physical activity and sleep apnea (β = −0.035, p = 0.002), endocrine/metabolic conditions (β = −0.033, p = 0.045) and total physical health (β = −0.091, p = 0.026) remained significant. Unexpectedly, time spent in sedentary behavior was negatively associated with musculoskeletal conditions (β = −0.017, p = 0.044). Findings indicate important associations between physical activity in everyday life and the physical and mental health of adults with Down syndrome. Social policies and interventions aimed at reducing time spent sitting around (i.e., sedentary behavior) and encouraging moderate‐to‐vigorous activity may be a low‐burden and low‐cost mechanism for fostering healthy physical and mental aging in the Down syndrome population.


  • Open Access

    Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndrome

    by Sigan L. Hartley, Victoria Fleming, Brianna Piro-Gambetti, Annie Cohen, Beau M. Ances, Michael A. Yassa, Adam M. Brickman, Benjamin L. Handen, Elizabeth Head, Mark Mapstone, et al.


  • Physical activity, cognitive decline and biomarkers of Alzheimer’s disease in adults with Down syndrome

    by Victoria Fleming, Brianna Piro‐Gambetti, Austin M Patrick, Matthew D Zammit, Andrew L Alexander, Bradley T Christian, Benjamin L Handen, Ann D Cohen, William E Klunk, Charles M Laymon, et al.

    Background: Adults with Down Syndrome (DS) are at high risk for Alzheimer's disease (AD), which is characterized by the early accumulation of amyloid‐beta (Aβ), followed by neurofibrillary tangles of tau, and subsequent pathology. There is variability in the age of AD onset in DS, which may mean that non‐genetic factors impact AD timing. Physical activity is associated with less age‐related cognitive declines and lower risk of AD in non‐DS populations. The goal of this study was to examine the association between physical activity and cognitive performance and AD biomarkers (Aβ PET, tau PET, and white matter (WM)) in non‐demented adults with DS.Methods: 66 adults with DS from the Alzheimer Biomarker Consortium Down Syndrome participated. Participants wore an actigraph accelerometer on their non‐dominant wrist for 7‐days. Cognitive performance was assessed via measures of memory, executive functioning, visuospatial ability, and dementia symptoms. Participants underwent MRI and PET scans to assess the standard uptake value ratio of [11C]PiB (15 mCi) in the neocortex and striatum and [18F]AV‐145 across braak regions I‐VI. WM integrity was assessed using DTI mean diffusivity and fractional anisotrophy in major association tracts.Results: Greater sedentary activity was associated with more dementia symptoms (r = ‐0.298, p<.05). Higher moderate‐to‐vigorous activity was associated with better memory (r = 0.309, p<.01), executive functioning (r = 0.270, p<.05), visuospatial ability (r = 0.311, p<.05), and fewer dementia symptoms (r = 0.356, p<.01). Models controlled for age and level of intellectual disability. Neither sedentary nor moderate‐to‐vigorous activity were significantly related to PET Aβ or tau PET. However, both were associated with WM integrity in the superior longitudinal fasciculus (r = ‐0.445, p<.05; r = 0.393, p<.05) and sedentary was associated with inferior longitudinal fasciculus tracts (r = ‐0.362, p<.05), after controlling for age and intellectual disability.Conclusion: Physical activity might have a protective effect against age‐related cognitive declines in in DS. However, the reverse time‐order could also be true. Physical activity was not associated with PET Aβ or tau PET cross‐sectionally. In contrast, physical activity was associated with WM integrity, Longitudinal studies are needed to understand mechanisms driving associations, including the cardiovascular impairment

  • Open Access

    Sleep and White Matter in Adults with Down Syndrome

    by Victoria Fleming, Brianna Piro-Gambetti, Austin Bazydlo, Matthew Zammit, Andrew L. Alexander, Bradley T. Christian, Benjamin Handen, David T. Plante, Sigan L. Hartley

    Adults with Down syndrome are at a high risk for disordered sleep. These sleep problems could have marked effects on aging and Alzheimer’s disease, potentially altering white matter integrity. This study examined the associations between disordered sleep assessed via an actigraph accelerometer worn on 7 consecutive nights, presence of diagnosis of obstructive sleep apnea, and diffusion tensor imaging indices of white matter integrity in 29 non-demented adults with Down Syndrome (48% female, aged 33–54 years). Average total sleep time was associated with lower mean diffusivity in the left superior longitudinal fasciculus (r = −0.398, p = 0.040). Average sleep efficiency, length of awakenings, and movement index were related to fractional anisotropy in the right inferior longitudinal fasciculus (r = −0.614 to 0.387, p ≤ 0.050). Diagnosis of obstructive sleep apnea was associated with fractional anisotropy in the right inferior longitudinal fasciculus (r = −0.373, p = 0.050). Findings suggest that more disrupted sleep is associated with lower white matter integrity in the major association tracts in middle-aged adults with Down syndrome. Longitudinal work is needed to confirm the directionally of associations. Sleep interventions could be an important component for promoting optimal brain aging in the Down syndrome population.